Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations

The summary for the Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control NCIRD, which is the U.S. government agency offering this grant.
Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations
Federal Grant Title: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations
Federal Agency Name: Centers for Disease Control NCIRD (HHS-CDC-NCIRD)
Grant Categories: Health
Type of Opportunity: Earmark
Funding Opportunity Number: RFA-IP-15-00203CONT17
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.185
CFDA Descriptions: Information not provided
Current Application Deadline: April 12th, 2017
Original Application Deadline: April 12th, 2017
Posted Date: February 9th, 2017
Creation Date: February 9th, 2017
Archive Date: May 12th, 2017
Total Program Funding: $0
Maximum Federal Grant Award: $0
Minimum Federal Grant Award: $0
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: February 9th, 2017
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP15-002: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations.
Grant Announcement Contact
Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS)
Technical Information Management Section (TIMS)
Phone: 770-488-2700

[email protected]
Similar Government Grants
Partnerships to Enhance Immunization Information Systems (IIS)
Advancing the capacity of immunization program managers through a national coordinating or...
Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health...
Developing a Public Health Tool to Predict the Virality of Vaccine Misinformation Narrativ...
Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
Coordination of Activities Between the CDC's National Immunization Program and the State a...
National Minority Organizations Immunization Projects
Using Provider Partnerships to Strengthen the Immunization Message
More Grants from the Centers for Disease Control NCIRD
Immunization and Vaccines for Children
Partnerships to Enhance Immunization Information Systems (IIS)
Advancing the capacity of immunization program managers through a national coordinating or...
Immunization Barriers in the United States: Targeting Medicaid Partnerships
Improving Standard Immunization Practices Among Pharmacists and Other Healthcare Providers

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com